Micropaque (Barium Sulfate)

Micropaque is a diagnostic contrast medium used for imaging of the gastrointestinal tract.

• Esophageal disorders: enables visualization of esophageal motility and structural lesions during a barium swallow.
• Upper gastrointestinal tract: provides detailed images of the stomach and duodenum for assessment of ulcers, tumors, and anatomy.
• Lower gastrointestinal tract: outlines the colon and rectum for detection of polyps, inflammation, strictures, or obstruction.
• Post‑surgical evaluation: helps assess anastomoses and surgical sites after gastrointestinal procedures.

• Barium sulfate is an inert, insoluble compound that, when ingested or administered rectally, coats the mucosal surfaces of the gastrointestinal tract. Its high atomic number strongly attenuates X‑ray photons, producing a radiopaque layer that enhances contrast on radiographic images, allowing clear delineation of the GI lumen without systemic absorption.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea or mild stomach upset.
• Abdominal cramping or discomfort.
• Constipation or temporary bowel irregularity.
• Altered taste sensation during oral administration.
• Mild diarrhea.
• Transient flatulence.

Serious or Rare Side Effects

• Allergic reaction, including rash, itching, or anaphylaxis.
• Aspiration of the suspension leading to pneumonia.
• Bowel obstruction or impaction, especially in patients with pre‑existing constipation.
• Gastrointestinal perforation, particularly if used in the presence of a suspected perforation.
• Severe dehydration from prolonged vomiting or diarrhea.
• Rare cases of severe electrolyte imbalance.

Before using Micropaque, consider the following safety measures.

• Assess for known hypersensitivity: avoid use in patients with documented barium sulfate allergy.
• Evaluate gastrointestinal integrity: contraindicated in suspected perforation, severe obstruction, or active inflammation.
• Consider alternative imaging: avoid in patients with severe constipation or ileus that may increase risk of impaction.
• Monitor fluid balance: ensure adequate hydration before and after administration to reduce risk of constipation.
• Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original container.

Micropaque may interact with other agents that affect imaging quality or gastrointestinal function.

Major Interactions (Avoid)

• Concurrent use of potassium iodide preparations: may interfere with radiographic interpretation.
• Co‑administration with antacids containing aluminum or magnesium: can reduce coating effectiveness.
• Use with other radiopaque contrast agents: may cause cumulative high attenuation and obscure images.

Moderate Interactions (Monitor Closely)

• Concurrent laxatives: may alter transit time and affect image quality.
• Use with oral antibiotics that affect gut flora: may change bowel motility and contrast distribution.
• Administration with other oral contrast agents for separate studies: schedule appropriately to avoid overlapping effects.